Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Patient Engagement Solutions Market by Component (Hardware, Software, Services), by Deployment Mode (On-premise, Cloud), by Functionality (Communication, Health Tracking and Insights, Biling and Payments, Administrative, Others), by End User (Providers, Payers, Patients): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00768

Pages: 32

Charts: 67

Tables: 153

Patient Engagement Solutions Market Insight, 2032

The global patient engagement solutions market size was valued at USD 17 billion in 2022, and is projected to reach USD 50.5 billion by 2032, growing at a CAGR of 11.5% from 2023 to 2032.

The global market size has currently experienced significant growth, primarily driven by the rise in awareness regarding mobile health among people. The rise in the trend of smartphone devices in several sectors and among individuals is directly influencing the growth of the global market growth. In addition, customers have increasingly used their mobile phones for health monitoring, with customers purchasing through mobile applications or mobile-optimized websites. Consequently, patient engagement solutions have gained significant adoption to increase the use of IT and control systems among healthcare operators, particularly smartphone usage and other digital technologies. The adoption of patient monitoring solutions is further fueled by growth in emphasis on electronic health record (EHR) reports.

Patient engagement solutions play a vital role in empowering patients to actively participate in their healthcare journey, fostering better patient outcomes and experiences. These patient engagement software and digital patient engagement platforms enable patients to access their medical information, schedule appointments, and communicate with healthcare providers, thereby allowing remote patient monitoring and encouraging shared decision-making. According to the study held by Accenture, 60% of patients are ready to use digital solutions to manage health conditions and communicate. Virtual tools are easy to adopt and are perceived as an essential lifeline for healthcare professionals.  

The report focuses on growth prospects, restraints, and trends of the patient engagement solutions market analysis. The study provides Porter’s five forces analysis to understand the impact of various factors, such as bargaining power of suppliers, competitive intensity of competitors, threat of new entrants, threat of substitutes, and bargaining power of buyers, on the market.

The patient engagement solutions market is segmented on the basis of component, deployment mode, functionality, end user, and region. On the basis of component, the market is segmented into hardware, software, and service. On the basis of deployment mode, the market is bifurcated into on-premise and cloud. On the basis of functionality, the market is segmented into communication, health tracking and insight, billing and payments, administrative, and others. On the basis of end user, the market is segmented into providers, payers and patients. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

[COMPONENTGRAPH]

On the basis of component, the global patient engagement solutions market share was dominated by the software segment in 2022 and is expected to maintain its dominance in the upcoming years, as the growth in need for a high level of personalization are one of the primary reasons enterprises have increased their investment in the market.

[REGIONGRAPH]

On the basis of region, North America dominated the market share in 2022 for the market. The presence of prominent players such as Oracle Corporation, IBM Corporation and others has influenced the growth of the patient engagement solutions market in North America. Moreover, a rise in government initiatives to strengthen healthcare infrastructure across the region is further expected to drive the demand for patient engagement solutions and services further anticipated to propel the growth of the patient engagement solutions industry.

However, Asia-Pacific is expected to exhibit the highest growth during the forecast period. This is attributed to the increase in penetration of digitalization and higher adoption of advanced technology are expected to provide lucrative growth opportunities for the market in this region.

Top Impacting Factors

Rise in Awareness Regarding Mobile Health Among People          

 The rise in the trend of smartphone devices in several sectors and among individuals is directly influencing the growth of the global patient engagement solutions market. In addition, customers have increasingly used their mobile phones for health monitoring, with customers purchasing through mobile applications or mobile-optimized websites. Consequently, patient engagement solutions have gained significant adoption to increase the use of IT and control systems among healthcare operators, particularly smartphone usage and other digital technologies.

In addition, increased use of smartphones and the internet helps consumers to easily access online healthcare platforms, by simply downloading the healthcare related application on their phones. Such ease of access has contributed to the high increasing adoption of patient engagement solutions, which in turn is expected to contribute to the increased installation of patient engagement solutions, globally.      

 Furthermore, the integration of smartphones and the internet solution enables an effective user experience for patient engagement solutions. Healthcare operators have increasingly presented mobile applications to interact with consumers and offer personalized healthcare experiences. Hence, these multiple benefits offered by smartphones and internet use in healthcare operations are anticipated to boost the demand for the market.

Moreover, several public and private organizations have continuously involved in promoting digitalization in analytical operations. For instance, in June 2023, Maxim Software Systems launched EngageB, a groundbreaking web application designed to transform patient engagement in dental clinics, which in turn, augments the market growth on a global scale. 

Extensive Investments Required for Healthcare Infrastructure     

The major challenge for the growth of global patient engagement solutions is high implementation and maintenance costs. The initial expenses associated with implementing patient engagement solutions generally relate to purchasing the program, setting up the infrastructure, and integrating it into current healthcare systems. These costs can vary based on the size of the organization, the complexity of the infrastructure, and the level of modification required.

In addition, patient engagement solutions often come with licensing or membership fees. These expenses are expected to be recurring, such as monthly or annual subscriptions, or one-time expense for ongoing licenses. This increase in upfront installation costs have restrained the adoption of patient engagement solutions across the globe. Furthermore, the integration of highly sophisticated technologies and components to provide efficient, reliable, and safe services.

However, these sophisticated technologies and equipment are expensive, and the design, development, and implementation of security systems involve high costs, which would be the major restraining factor for the growth of the global market. In addition, these technically advanced systems entail a combination of electronic components and several subsystems to offer real-time patient data to the business authority. It usually costs billions of dollars and more installation time compared to the conventional system, which leads to less preference among security operators. Therefore, both the cost and time, which are required for the installation and development of healthcare technologies in patient engagement solutions would prove to be the major obstacle to this market growth across the globe.   

High Complexity Associated with the Integration of Advanced Solutions with Existing Healthcare Infrastructure Components        

Integration complexities of patient engagement solutions are the key constraints for the growth of the global market. Businesses frequently utilize a range of apps and software using various technologies. The process of integrating a patient engagement solution can be complicated since it may need to operate with several platforms, databases, and technologies.

Furthermore, while patient engagement solutions offer numerous benefits such as flexibility, scalability, and cost-effectiveness, organizations and individuals often hesitate to fully adopt patient engagement solutions due to its adoption challenges to the user. Appropriate change management techniques are needed to guarantee user acceptability while introducing a new patient engagement solution. It may take some time to provide the new system with training and support. These threats cause business operations to be restricted in an unplanned manner, which negatively impacts punctuality and the allocation of resources in patient engagement solutions.

Moreover, patient engagement solutions may involve data being stored and processed in different geographic locations, which raises concerns about data residency and jurisdictional requirements. Thus, such measures have hindered the growth of the patient engagement solutions market.   

Competition Analysis:

Competitive analysis and profiles of the major players in the Aetna Inc., Allscripts Healthcare Solutions, Inc. (Veradigm LLC), Athenahealth, Oracle Corporation, EPIC Systems Corporation, GetWellNetwork, Inc., IBM Corporation, IQVIA Inc., Lumeon Inc., McKesson Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which help to drive the growth of the patient engagement solutions market globally.

Recent partnerships in the Market:

For instance, in October 2023, Axxess partnered with Sulos, to prioritize transparency and early intervention to elevate healthcare outcomes. The partnership further harnesses data, especially between visits, to point patients in need of support, which can significantly reduce hospital readmissions and the need for emergency care. Thus, such strategies are further expected to propel numerous growth opportunities for the global market. 

Recent product launches in the Market:

For instance, in June 2023, Maxim Software Systems launched EngageB, a web application designed to transform patient engagement in dental clinics. EngageB represents a significant leap forward in patient communication and relationship management. Therefore, such strategies adopted by market players have increased market competition and leading the growth of the market.

Market landscape and Trends

The patient engagement solutions market has witnessed significant growth in the past few years; due to the outbreak of the COVID-19 pandemic, the market witnessed a sudden increase in demand during the period. This was attributed to the fact that there was an increase in demand for healthcare services, as businesses were moving to capitalize on the increased automation and digitalization in the healthcare sector.

Furthermore, the rise in the number of COVID-19 cases influenced governments and local authorities to enforce strict measures such as social distancing and self-isolation policies to the closing of physical shops and businesses. This was intended to help slow the spread of COVID-19 cases, which further caused a growth in number of businesses depending on digital technologies. Such trends accelerated the digital transformation of physical businesses during the period of the pandemic. On the other hand, the economic uncertainties caused by the pandemic prompted organizations to seek cost-efficient solutions. Consequently, organizations could quickly scale up their business solutions deployments in the cloud to accommodate a large number of remote users without the need for significant infrastructure investments.

For instance, in February 2021, Humana Inc. Collaborated with IBM, to leverage  conversational AI solution of IBM – to help provide a better member experience while providing greater clarity and transparency on benefits and other related matters for Humana Employer Group members. This is expected to boost the demand for patient engagement solutions among large and small organizations.      

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient engagement solutions market forecast from 2022 to 2032 to identify the prevailing market opportunities.
  • Market research is offered along with information related to key drivers, restraints, and opportunities of market outlook.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  •  In-depth analysis of the market segmentation assists in determining the prevailing patient engagement solutions market opportunity.
  • Major countries in each region are mapped according to their revenue contribution to the global patient engagement solutions market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes an analysis of the regional as well as global patient engagement solutions market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By End User
    • Providers
    • Payers
    • Patients
  • By Component
    • Hardware
    • Software
    • Services
  • By Deployment Mode
    • On-premise
    • Cloud
  • By Functionality
    • Communication
    • Health Tracking and Insights
    • Biling and Payments
    • Administrative
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa


Key Market Players

  • Lumeon Inc.
  • McKesson Corporation.
  • EPIC Systems Corporation
  • Oracle Corporation
  • GetWellNetwork, Inc.
  • IBM Corporation
  • Allscripts Healthcare Solutions, Inc. (Veradigm LLC)
  • Aetna Inc.
  • IQVIA Inc.
  • Athenahealth
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Low threat of new entrants

      • 3.3.2. Low threat of substitutes

      • 3.3.3. Low intensity of rivalry

      • 3.3.4. Low bargaining power of buyers

      • 3.3.5. Low bargaining power of suppliers

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Rise in awareness regarding mobile health among people
        • 3.4.1.2. Growth in emphasis on electronic health record (EHR) reports
      • 3.4.2. Restraints

        • 3.4.2.1. Extensive investments required for healthcare infrastructure
        • 3.4.2.2. High complexity associated with the integration of advanced solutions with existing healthcare infrastructure components
      • 3.4.3. Opportunities

        • 3.4.3.1. Rise in significance of cloud computing technologies to deliver remote patient monitoring and assistance services
  • CHAPTER 4: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Hardware

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Software

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Services

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

  • CHAPTER 5: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. On-premise

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Cloud

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

  • CHAPTER 6: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Communication

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Health Tracking and Insights

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Biling and Payments

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

    • 6.5. Administrative

      • 6.5.1. Key market trends, growth factors and opportunities

      • 6.5.2. Market size and forecast, by region

      • 6.5.3. Market share analysis by country

    • 6.6. Others

      • 6.6.1. Key market trends, growth factors and opportunities

      • 6.6.2. Market size and forecast, by region

      • 6.6.3. Market share analysis by country

  • CHAPTER 7: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER

    • 7.1. Overview

      • 7.1.1. Market size and forecast

    • 7.2. Providers

      • 7.2.1. Key market trends, growth factors and opportunities

      • 7.2.2. Market size and forecast, by region

      • 7.2.3. Market share analysis by country

    • 7.3. Payers

      • 7.3.1. Key market trends, growth factors and opportunities

      • 7.3.2. Market size and forecast, by region

      • 7.3.3. Market share analysis by country

    • 7.4. Patients

      • 7.4.1. Key market trends, growth factors and opportunities

      • 7.4.2. Market size and forecast, by region

      • 7.4.3. Market share analysis by country

  • CHAPTER 8: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION

    • 8.1. Overview

      • 8.1.1. Market size and forecast By Region

    • 8.2. North America

      • 8.2.1. Key market trends, growth factors and opportunities

      • 8.2.2. Market size and forecast, by Component

      • 8.2.3. Market size and forecast, by Deployment Mode

      • 8.2.4. Market size and forecast, by Functionality

      • 8.2.5. Market size and forecast, by End User

      • 8.2.6. Market size and forecast, by country

        • 8.2.6.1. U.S.
          • 8.2.6.1.1. Market size and forecast, by Component
          • 8.2.6.1.2. Market size and forecast, by Deployment Mode
          • 8.2.6.1.3. Market size and forecast, by Functionality
          • 8.2.6.1.4. Market size and forecast, by End User
        • 8.2.6.2. Canada
          • 8.2.6.2.1. Market size and forecast, by Component
          • 8.2.6.2.2. Market size and forecast, by Deployment Mode
          • 8.2.6.2.3. Market size and forecast, by Functionality
          • 8.2.6.2.4. Market size and forecast, by End User
    • 8.3. Europe

      • 8.3.1. Key market trends, growth factors and opportunities

      • 8.3.2. Market size and forecast, by Component

      • 8.3.3. Market size and forecast, by Deployment Mode

      • 8.3.4. Market size and forecast, by Functionality

      • 8.3.5. Market size and forecast, by End User

      • 8.3.6. Market size and forecast, by country

        • 8.3.6.1. UK
          • 8.3.6.1.1. Market size and forecast, by Component
          • 8.3.6.1.2. Market size and forecast, by Deployment Mode
          • 8.3.6.1.3. Market size and forecast, by Functionality
          • 8.3.6.1.4. Market size and forecast, by End User
        • 8.3.6.2. Germany
          • 8.3.6.2.1. Market size and forecast, by Component
          • 8.3.6.2.2. Market size and forecast, by Deployment Mode
          • 8.3.6.2.3. Market size and forecast, by Functionality
          • 8.3.6.2.4. Market size and forecast, by End User
        • 8.3.6.3. France
          • 8.3.6.3.1. Market size and forecast, by Component
          • 8.3.6.3.2. Market size and forecast, by Deployment Mode
          • 8.3.6.3.3. Market size and forecast, by Functionality
          • 8.3.6.3.4. Market size and forecast, by End User
        • 8.3.6.4. Italy
          • 8.3.6.4.1. Market size and forecast, by Component
          • 8.3.6.4.2. Market size and forecast, by Deployment Mode
          • 8.3.6.4.3. Market size and forecast, by Functionality
          • 8.3.6.4.4. Market size and forecast, by End User
        • 8.3.6.5. Spain
          • 8.3.6.5.1. Market size and forecast, by Component
          • 8.3.6.5.2. Market size and forecast, by Deployment Mode
          • 8.3.6.5.3. Market size and forecast, by Functionality
          • 8.3.6.5.4. Market size and forecast, by End User
        • 8.3.6.6. Rest of Europe
          • 8.3.6.6.1. Market size and forecast, by Component
          • 8.3.6.6.2. Market size and forecast, by Deployment Mode
          • 8.3.6.6.3. Market size and forecast, by Functionality
          • 8.3.6.6.4. Market size and forecast, by End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key market trends, growth factors and opportunities

      • 8.4.2. Market size and forecast, by Component

      • 8.4.3. Market size and forecast, by Deployment Mode

      • 8.4.4. Market size and forecast, by Functionality

      • 8.4.5. Market size and forecast, by End User

      • 8.4.6. Market size and forecast, by country

        • 8.4.6.1. China
          • 8.4.6.1.1. Market size and forecast, by Component
          • 8.4.6.1.2. Market size and forecast, by Deployment Mode
          • 8.4.6.1.3. Market size and forecast, by Functionality
          • 8.4.6.1.4. Market size and forecast, by End User
        • 8.4.6.2. Japan
          • 8.4.6.2.1. Market size and forecast, by Component
          • 8.4.6.2.2. Market size and forecast, by Deployment Mode
          • 8.4.6.2.3. Market size and forecast, by Functionality
          • 8.4.6.2.4. Market size and forecast, by End User
        • 8.4.6.3. India
          • 8.4.6.3.1. Market size and forecast, by Component
          • 8.4.6.3.2. Market size and forecast, by Deployment Mode
          • 8.4.6.3.3. Market size and forecast, by Functionality
          • 8.4.6.3.4. Market size and forecast, by End User
        • 8.4.6.4. Australia
          • 8.4.6.4.1. Market size and forecast, by Component
          • 8.4.6.4.2. Market size and forecast, by Deployment Mode
          • 8.4.6.4.3. Market size and forecast, by Functionality
          • 8.4.6.4.4. Market size and forecast, by End User
        • 8.4.6.5. South Korea
          • 8.4.6.5.1. Market size and forecast, by Component
          • 8.4.6.5.2. Market size and forecast, by Deployment Mode
          • 8.4.6.5.3. Market size and forecast, by Functionality
          • 8.4.6.5.4. Market size and forecast, by End User
        • 8.4.6.6. Rest of Asia-Pacific
          • 8.4.6.6.1. Market size and forecast, by Component
          • 8.4.6.6.2. Market size and forecast, by Deployment Mode
          • 8.4.6.6.3. Market size and forecast, by Functionality
          • 8.4.6.6.4. Market size and forecast, by End User
    • 8.5. LAMEA

      • 8.5.1. Key market trends, growth factors and opportunities

      • 8.5.2. Market size and forecast, by Component

      • 8.5.3. Market size and forecast, by Deployment Mode

      • 8.5.4. Market size and forecast, by Functionality

      • 8.5.5. Market size and forecast, by End User

      • 8.5.6. Market size and forecast, by country

        • 8.5.6.1. Latin America
          • 8.5.6.1.1. Market size and forecast, by Component
          • 8.5.6.1.2. Market size and forecast, by Deployment Mode
          • 8.5.6.1.3. Market size and forecast, by Functionality
          • 8.5.6.1.4. Market size and forecast, by End User
        • 8.5.6.2. Middle East
          • 8.5.6.2.1. Market size and forecast, by Component
          • 8.5.6.2.2. Market size and forecast, by Deployment Mode
          • 8.5.6.2.3. Market size and forecast, by Functionality
          • 8.5.6.2.4. Market size and forecast, by End User
        • 8.5.6.3. Africa
          • 8.5.6.3.1. Market size and forecast, by Component
          • 8.5.6.3.2. Market size and forecast, by Deployment Mode
          • 8.5.6.3.3. Market size and forecast, by Functionality
          • 8.5.6.3.4. Market size and forecast, by End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product mapping of top 10 player

    • 9.4. Competitive dashboard

    • 9.5. Competitive heatmap

    • 9.6. Top player positioning, 2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Aetna Inc.

      • 10.1.1. Company overview

      • 10.1.2. Key executives

      • 10.1.3. Company snapshot

      • 10.1.4. Operating business segments

      • 10.1.5. Product portfolio

      • 10.1.6. Business performance

      • 10.1.7. Key strategic moves and developments

    • 10.2. Allscripts Healthcare Solutions, Inc. (Veradigm LLC)

      • 10.2.1. Company overview

      • 10.2.2. Key executives

      • 10.2.3. Company snapshot

      • 10.2.4. Operating business segments

      • 10.2.5. Product portfolio

      • 10.2.6. Business performance

    • 10.3. Athenahealth

      • 10.3.1. Company overview

      • 10.3.2. Key executives

      • 10.3.3. Company snapshot

      • 10.3.4. Operating business segments

      • 10.3.5. Product portfolio

      • 10.3.6. Key strategic moves and developments

    • 10.4. Oracle Corporation

      • 10.4.1. Company overview

      • 10.4.2. Key executives

      • 10.4.3. Company snapshot

      • 10.4.4. Operating business segments

      • 10.4.5. Product portfolio

      • 10.4.6. Business performance

      • 10.4.7. Key strategic moves and developments

    • 10.5. EPIC Systems Corporation

      • 10.5.1. Company overview

      • 10.5.2. Key executives

      • 10.5.3. Company snapshot

      • 10.5.4. Operating business segments

      • 10.5.5. Product portfolio

      • 10.5.6. Key strategic moves and developments

    • 10.6. GetWellNetwork, Inc.

      • 10.6.1. Company overview

      • 10.6.2. Key executives

      • 10.6.3. Company snapshot

      • 10.6.4. Operating business segments

      • 10.6.5. Product portfolio

      • 10.6.6. Key strategic moves and developments

    • 10.7. IBM Corporation

      • 10.7.1. Company overview

      • 10.7.2. Key executives

      • 10.7.3. Company snapshot

      • 10.7.4. Operating business segments

      • 10.7.5. Product portfolio

      • 10.7.6. Business performance

    • 10.8. IQVIA Inc.

      • 10.8.1. Company overview

      • 10.8.2. Key executives

      • 10.8.3. Company snapshot

      • 10.8.4. Operating business segments

      • 10.8.5. Product portfolio

      • 10.8.6. Business performance

      • 10.8.7. Key strategic moves and developments

    • 10.9. Lumeon Inc.

      • 10.9.1. Company overview

      • 10.9.2. Key executives

      • 10.9.3. Company snapshot

      • 10.9.4. Operating business segments

      • 10.9.5. Product portfolio

    • 10.10. McKesson Corporation.

      • 10.10.1. Company overview

      • 10.10.2. Key executives

      • 10.10.3. Company snapshot

      • 10.10.4. Operating business segments

      • 10.10.5. Product portfolio

      • 10.10.6. Business performance

      • 10.10.7. Key strategic moves and developments

  • LIST OF FIGURES

  • FIGURE 01. PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032
    FIGURE 02. SEGMENTATION OF PATIENT ENGAGEMENT SOLUTIONS MARKET,2022-2032
    FIGURE 03. TOP IMPACTING FACTORS IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2022 TO 2032)
    FIGURE 04. TOP INVESTMENT POCKETS IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2023-2032)
    FIGURE 05. LOW THREAT OF NEW ENTRANTS
    FIGURE 06. LOW THREAT OF SUBSTITUTES
    FIGURE 07. LOW INTENSITY OF RIVALRY
    FIGURE 08. LOW BARGAINING POWER OF BUYERS
    FIGURE 09. LOW BARGAINING POWER OF SUPPLIERS
    FIGURE 10. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 AND 2032(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY 2022 AND 2032(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022 AND 2032(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE, BY COUNTRY 2022 AND 2032(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD, BY COUNTRY 2022 AND 2032(%)
    FIGURE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022 AND 2032(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR COMMUNICATION, BY COUNTRY 2022 AND 2032(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH TRACKING AND INSIGHTS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILING AND PAYMENTS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ADMINISTRATIVE, BY COUNTRY 2022 AND 2032(%)
    FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022 AND 2032(%)
    FIGURE 25. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 26. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 27. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET BY REGION, 2022 AND 2032(%)
    FIGURE 29. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 30. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 31. UK PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 32. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 33. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 34. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 35. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 36. REST OF EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 37. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 38. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 39. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 40. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 41. SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 42. REST OF ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 43. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 44. MIDDLE EAST PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 45. AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
    FIGURE 46. TOP WINNING STRATEGIES, BY YEAR (2022-2023)
    FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2023)
    FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY (2022-2023)
    FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 50. COMPETITIVE DASHBOARD
    FIGURE 51. COMPETITIVE HEATMAP: PATIENT ENGAGEMENT SOLUTIONS MARKET
    FIGURE 52. TOP PLAYER POSITIONING, 2022
    FIGURE 53. AETNA INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 54. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): NET SALES, 2019-2021 ($MILLION)
    FIGURE 55. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 56. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 57. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 58. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 59. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 60. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
    FIGURE 61. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 62. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 63. IQVIA INC.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 64. IQVIA INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 65. IQVIA INC.: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 66. MCKESSON CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 67. MCKESSON CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)

Purchase Full Report of
Patient Engagement Solutions Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue